Industries

SCA Sweeping Corporation of America Buys Sweeping South and Accusweep in South Carolina

Monday, August 3, 2020 - 1:00pm

CLEVELAND, Aug. 3, 2020 /PRNewswire/ --SCA Sweeping Corporation of America ("SCA"), the largest power sweeping company in the United States, has acquired Moncks Corner, South Carolina-based Sweeping South, Inc. ("Sweeping South") and Columbia, South Carolina-based Accusweep Services, Inc. ("Accusweep").With these transactions, SCA now has over 1,000 employees in its 35 locations throughout the eastern half of the United States.

Key Points: 
  • CLEVELAND, Aug. 3, 2020 /PRNewswire/ --SCA Sweeping Corporation of America ("SCA"), the largest power sweeping company in the United States, has acquired Moncks Corner, South Carolina-based Sweeping South, Inc. ("Sweeping South") and Columbia, South Carolina-based Accusweep Services, Inc. ("Accusweep").With these transactions, SCA now has over 1,000 employees in its 35 locations throughout the eastern half of the United States.
  • About SCA:Headquartered in Cleveland, Ohio, SCA is the largest power sweeping services company in the United States.
  • SCA self-performs power sweeping for highways, streets, industrial and commercial applications for both private and government entities.
  • About Sweeping South:Formerly owned by Nicki and Don Knapp, Sweeping South opened its doors in 2001 and has become the Charleston, South Carolina, area's leading power street and parking lot sweeping services company.

Broadcom Inc. to Announce Third Quarter Fiscal Year 2020 Financial Results on Thursday, September 3, 2020

Monday, August 3, 2020 - 1:00pm

SAN JOSE, Calif., Aug. 3, 2020 /PRNewswire/ --Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its third quarter fiscal year 2020 financial results and business outlook on Thursday, September 3, 2020 after the close of the market.

Key Points: 
  • SAN JOSE, Calif., Aug. 3, 2020 /PRNewswire/ --Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its third quarter fiscal year 2020 financial results and business outlook on Thursday, September 3, 2020 after the close of the market.
  • Broadcom's management will host a conference call at 2:00 p.m. Pacific Time on the same day to discuss these results and business outlook.
  • Broadcom Inc., (NASDAQ: AVGO), a Delaware corporation headquartered in San Jose, CA, is a global technology leader that designs, develops and supplies a broad range of semiconductor and infrastructure software solutions.
  • Broadcom's category-leading product portfolio serves critical markets including data center, networking, enterprise software, broadband, wireless, storage and industrial.

Tyson Foods Names Dean Banks to Succeed Noel White as Chief Executive Officer on October 3, 2020

Monday, August 3, 2020 - 12:30pm

Banks is currently president and a non-independent director; White elevated to role on Board as Executive Vice Chairman

Key Points: 
  • Banks is currently president and a non-independent director; White elevated to role on Board as Executive Vice Chairman
    SPRINGDALE, Ark., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) today announced that Dean Banks will succeed Noel White as Chief Executive Officer (CEO), while maintaining the role of President, effective October 3, 2020.
  • Since joining Tyson Foods as a director in 2017 and his appointment as President in 2019, Banks has worked closely with Tyson leadership to develop a greater understanding of the business and strategic vision for future growth.
  • Noel White has been a dedicated member of the Tyson team since joining the company through the IBP acquisition in 2001.
  • Tyson Foods, Inc. (NYSE: TSN) is one of the worlds largest food companies and a recognized leader in protein.

Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and Webcast

Monday, August 3, 2020 - 12:30pm

(NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will release its financial results for the second quarter ended June 30, 2020 before the U.S. financial markets open on Monday, August 10, 2020.

Key Points: 
  • (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will release its financial results for the second quarter ended June 30, 2020 before the U.S. financial markets open on Monday, August 10, 2020.
  • Management will host a conference call on August 10, 2020 at 8:30 a.m.
  • ET to discuss these results and provide an update on the Company.
  • To access the live webcast or the replay, visit the Company's website www.momentapharma.com and click on the Investors and News tab.

UroGen Pharma to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020

Monday, August 3, 2020 - 1:00pm

UroGen Pharma Ltd. (Nasdaq:URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases, today announced that it will report second quarter 2020 financial results on Monday, August 10, 2020, prior to the open of the market.

Key Points: 
  • UroGen Pharma Ltd. (Nasdaq:URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases, today announced that it will report second quarter 2020 financial results on Monday, August 10, 2020, prior to the open of the market.
  • The announcement will be followed by a live audio webcast and conference call at 8:30 AM Eastern Time.
  • The webcast will be made available on the Investors section of the Companys website at http://investors.urogen.com .
  • UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options.

Allied Esports Launches New North American Online Tournament Format and Schedule

Monday, August 3, 2020 - 1:00pm

Allied Esports, a global esports entertainment company and a subsidiary of Allied Esports Entertainment, Inc. (NASDAQ: AESE), today announced a new North American online tournament format and schedule featuring month-long series and single day pop-up events across various game titles.

Key Points: 
  • Allied Esports, a global esports entertainment company and a subsidiary of Allied Esports Entertainment, Inc. (NASDAQ: AESE), today announced a new North American online tournament format and schedule featuring month-long series and single day pop-up events across various game titles.
  • For a complete schedule of events, tournament rules and to register, visit alliedesports.gg/onlinetournaments and join the Allied Esports Discord server.
  • Allied Esports North American online tournaments were started in March 2020 when live events at the companys flagship venue, HyperX Esports Arena Las Vegas, were postponed due to the COVID-19 pandemic.
  • Through direct operation or membership in the Allied Esports Property Network, the worlds first esports affiliate program, Allied Esports facilities span North America, Europe, China and Australia, and include the world-renowned HyperX Esports Arena Las Vegas, a fleet of mobile arenas, the HyperX Esports Trucks, and the HyperX Esports Studio in Hamburg, Germany.

Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update

Monday, August 3, 2020 - 12:00pm

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2020 financial results and provide a corporate update on Monday, August 10, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

Key Points: 
  • Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2020 financial results and provide a corporate update on Monday, August 10, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific.
  • Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies.
  • SPECTRUM PHARMACEUTICALS, INC. is a registered trademark of Spectrum Pharmaceuticals, Inc and its affiliate.
  • REDEFINING CANCER CARE and the Spectrum Pharmaceuticals logos are trademarks owned by Spectrum Pharmaceuticals, Inc. Any other trademarks are the property of their respective owners.

BD releases FY 2019 Sustainability Report

Monday, August 3, 2020 - 11:58am

FRANKLIN LAKES, N.J., Aug. 3, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company's 2020 Sustainability Goals from October 1, 2018 to September 30, 2019 (FY 2019).

Key Points: 
  • FRANKLIN LAKES, N.J., Aug. 3, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company's 2020 Sustainability Goals from October 1, 2018 to September 30, 2019 (FY 2019).
  • Over the course of FY 2019, the company identified more than 200 energy reduction projects that will amount to over $5 million in energy savings, once completed.
  • "We are proud of our accomplishments in FY 2019, but we will never be satisfied with maintaining the status quo," said Tom Polen, CEO and president.
  • For more information about the company's sustainability goals, view the2019 Sustainability Report here: https://www.bd.com/en-us/company/sustainability-at-bd .

Microbot Medical Appoints the Co-Founder of Corindus Vascular Robotics to its Board of Directors

Monday, August 3, 2020 - 12:00pm

Mr. Wenderow co-founded Corindus Vascular Robotics, a robotic-assisted vascular interventions company, and contributed to the companys success, leading to its $1.1 billion acquisition by Siemens Healthineers AG in October 2019.

Key Points: 
  • Mr. Wenderow co-founded Corindus Vascular Robotics, a robotic-assisted vascular interventions company, and contributed to the companys success, leading to its $1.1 billion acquisition by Siemens Healthineers AG in October 2019.
  • His contributions to Corindus growth, from inception through the recently completed acquisition by Siemens Healthineers AG, are well chronicled.
  • I am extremely excited to join the Microbot Board of Directors and support the next revolution of the healthcare robotic space, commented Mr. Wenderow.
  • Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Plus Therapeutics To Report Second Quarter Fiscal Year 2020 Financial Results And Corporate Update on August 10, 2020

Monday, August 3, 2020 - 12:00pm

Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionucleotides for several cancer targets.

Key Points: 
  • Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionucleotides for several cancer targets.
  • Central to the Companys drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases.
  • The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers.
  • This press release contains certain statements that may be deemed forward-looking statements within the meaning of U.S. securities laws.